Envista Holdings (NVST) Liabilities and Shareholders Equity (2017 - 2026)

Envista Holdings (NVST) recorded quarterly Liabilities and Shareholders Equity of $5.6 billion in Q2 2026, down 1.78% quarter-over-quarter from $5.7 billion in Q4 2025, and up 2.04% on a YoY basis from $5.5 billion in Q2 2025.

Envista Holdings (NVST) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

Envista Holdings' Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $5.6 billion for Q2 2026.

  • In Q2 2026, Liabilities and Shareholders Equity rose 2.04% year-over-year to $5.6 billion; the TTM figure through Apr 2026 stood at $22.6 billion (up 3.67% YoY), while the FY2025 annual figure was $5.7 billion, up 6.14% from the prior year.
  • Liabilities and Shareholders Equity was $5.6 billion for Q2 2026 at Envista Holdings, down from $5.7 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $6.7 billion in Q3 2023 to a low of $5.4 billion in Q4 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $6.1 billion across 5 years, with a median of $6.4 billion in 2022.
  • The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity decreased 18.99% in 2024, then increased 6.14% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $6.6 billion in 2022, then advanced by 0.27% to $6.6 billion in 2023, then slipped by 18.99% to $5.4 billion in 2024, then gained by 6.14% to $5.7 billion in 2025, then decreased by 1.78% to $5.6 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $5.6 billion (Q2 2026), $5.7 billion (Q4 2025), and $5.6 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 20.11 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 50.83 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 39.01 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 8.78 Bn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 4.11 Bn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 14.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 12.48 Bn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 6.31 Bn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 19.85 Bn
10 Envista Holdings 4.06 Bn 2.98 Bn 390.10 Mn 5.58 Bn

Historic Data

Download Data
DateValue
Apr 3, 2026 5.58 Bn
Dec 31, 2025 5.68 Bn
Sep 26, 2025 5.64 Bn
Jun 27, 2025 5.66 Bn
Mar 28, 2025 5.47 Bn
Dec 31, 2024 5.35 Bn
Sep 27, 2024 5.51 Bn
Jun 28, 2024 5.44 Bn
Mar 29, 2024 6.56 Bn
Dec 31, 2023 6.61 Bn
Sep 29, 2023 6.68 Bn
Jun 30, 2023 6.61 Bn
Mar 31, 2023 6.58 Bn
Dec 31, 2022 6.59 Bn
Sep 30, 2022 6.41 Bn
Jul 1, 2022 6.46 Bn
Apr 1, 2022 6.57 Bn
Dec 31, 2021 6.57 Bn
Oct 1, 2021 6.56 Bn
Jul 2, 2021 6.48 Bn